OpSec Security, the global leader in physical and digital anti-counterfeiting and brand protection solutions, announces a COVID-19 testing kit authentication and traceability solution.
With exponential growth in global demand for coronavirus test kits, criminals have infiltrated the supply chain with mass volumes of potentially life-threatening counterfeit, low quality kits. This challenge will only increase as testing continues to expand and, potentially, extended in-home.
OpSec addresses the need of governments, healthcare professionals, law enforcement, and consumers to ensure the integrity and authenticity of tests kits and future cures. The COVID-19 Authentication & Traceability Solution (CATS) integrates OpSec’s proven SecureITT authentication label, which encompasses innovative security features, with the OpSec InSight™ track and trace platform providing full supply-chain transparency. Additionally, OpSec Online reduces online exposure to illegitimate tests by detecting and enforcing against their sales across the web.
The continued rise in imitation COVID-19 testing kits and pharmaceutical products reveals increasing risks to vulnerable consumers. OpSec’s unique ability to address both the physical supply chain and online distribution channels enables us to provide an integrated solution that delivers confidence and dependability.”
Selva Selvaratnam, CEO of OpSec Security
Study finds nirmatrelvir-ritonavir reduces severe COVID-19 and long COVID risks in high-risk patients